In this newsletter we take a look at two recently published books that represent two ends of the spectrum of neurofeedback approaches. They reflect divisions within the field that have remained unreconciled over the decades. They also reflect their authors, who have taken very different approaches in their scientific research. The Open Focus Brain This […]
Sometimes we who work with neurofeedback have the impression of living in a parallel universe. We live with a view of reality that is attaining increasing confirmation via formal studies while at the same time becoming much more clinically effective, yet it is a view that appears to be almost completely disconnected from mainstream thinking. […]
We have just seen the new movie, The Diving Bell and the Butterfly, which opened here recently in limited release. I had read the book some years ago because of its graphic telling of the story of locked-in syndrome. Jean-Dominique Bauby, editor of the French edition of Elle, had a brainstem stroke that left him […]
Much proposed research on neurofeedback has faltered over the years on the issue of uniformity of approach. The protocol to be investigated needs to be narrowly constrained or the research will be criticized for a lack of specificity. We have had a number conversations over the years with researchers who were willing to give Neurofeedback […]
Ever since Larry Summers broached the issue in 2005 of whether intrinsic biological factors might have something to do with the low entry rate of women into certain science disciplines I have been accumulating a file of clippings on this general issue. Just recently the controversy has come up again in two forms. First of […]
Comparison Shopping in Medicines
A few weeks ago the Economist Magazine offered up the lament that comparison shopping is very difficult to do when it comes to medications because the underlying studies have not been done. It is difficult enough for pharmaceutical companies to get new drugs past their regulatory hurdles via Randomized Controlled Trials against a placebo control. […]